TPC-1, RRM2 -OE-TPC-1 mRNA sequencing and KEGG pathway analysis showed that the PI3K-Akt signaling pathway was significantly enriched in the differential genes
Intended Use This kit is designed exclusively for: Laboratory research In-vitro experimentation Biochemical pathway modeling Peptide-receptor interaction studies Non-human preclinical research Academic and institutional scientific work Not intended for: Human or animal use Injection, ingestion, inhalation, or topical administration Medical, therapeutic, diagnostic, or health-related purposes This compound is not approved by Health Canada, FDA, or any regulatory body for clinical application
Frequency: Once per day (subcutaneous), preferably evening/bedtime
You should not use NAD+ if you have a known allergy to NAD+ or any ingredient in the injection
Accessed 2 May 2021
Hence, there is a critical need for systematic investigations into EGCGs bioavailability, toxicity profile, and appropriate dosing regimens
